Cancer Biology & Therapy,
Год журнала:
2025,
Номер
26(1)
Опубликована: Фев. 4, 2025
Acute
lymphocytic
leukemia
(ALL)
is
the
most
common
in
children,
with
T-cell
subtype
(T-ALL)
accounting
for
15%
of
those
cases.
Despite
advancements
treatment
T-ALL,
patients
still
face
a
dismal
prognosis
following
their
first
relapse.
Relapse
can
be
attributed
to
inability
chemotherapy
agents
eradicate
stem
cells
(LSC),
which
possess
self-renewal
capabilities
and
are
responsible
long-term
maintenance
disease.
Mitochondria
have
been
recognized
as
therapeutic
vulnerability
cancer
cells,
including
LSCs.
Mitocans
shown
promise
T-ALL
both
vitro
vivo,
some
currently
early-phase
clinical
trials.
However,
due
challenges
studying
LSCs
our
understanding
how
mitochondrial
function
influences
remains
limited.
This
review
highlights
emerging
literature
on
targeting
mitochondria
diverse
models,
emphasizing
specific
vulnerabilities
linked
LSC
potential
significantly
improve
treatment.
Cancers,
Год журнала:
2021,
Номер
13(13), С. 3311 - 3311
Опубликована: Июль 1, 2021
Carcinogenesis
is
a
multi-step
process
that
refers
to
transformation
of
normal
cell
into
tumoral
neoplastic
cell.
The
mechanisms
promote
tumor
initiation,
promotion
and
progression
are
varied,
complex
remain
be
understood.
Studies
have
highlighted
the
involvement
oncogenic
mutations,
genomic
instability
epigenetic
alterations
as
well
metabolic
reprogramming,
in
different
processes
oncogenesis.
However,
underlying
still
clarified.
Mitochondria
central
organelles
at
crossroad
various
energetic
metabolisms.
In
addition
their
pivotal
roles
bioenergetic
metabolism,
they
control
redox
homeostasis,
biosynthesis
macromolecules
apoptotic
signals,
all
which
linked
carcinogenesis.
present
review,
we
discuss
how
mitochondria
contribute
initiation
carcinogenesis
through
gene
mutations
production
oncometabolites,
reprogramming
mitochondrial
dynamics.
Finally,
metabolism
promising
target
for
development
novel
therapeutic
strategies.
Trends in cancer,
Год журнала:
2023,
Номер
9(4), С. 293 - 308
Опубликована: Фев. 15, 2023
Most
cancer-related
deaths
among
patients
with
solid
tumors
are
caused
by
metastases.
Migrastatic
strategies
represent
a
unique
therapeutic
approach
to
prevent
all
forms
of
cancer
cell
migration
and
invasion.
Because
the
machinery
has
been
shown
promote
metastatic
dissemination,
successful
migrastatic
therapy
may
reduce
need
for
high-dose
cytotoxic
therapies
that
currently
used
risk
dissemination.
In
this
review
we
focus
on
anti-invasive
antimetastatic
hold
promise
treatment
tumors.
The
best
targets
would
be
those
required
motility,
such
as
ATP
availability,
mitochondrial
metabolism,
cytoskeletal
dynamics
contractility.
Cellular Signalling,
Год журнала:
2023,
Номер
109, С. 110794 - 110794
Опубликована: Июль 6, 2023
Traditionally,
mitochondria
are
known
as
"the
powerhouse
of
the
cell,"
responsible
for
energy
(ATP)
generation
(by
electron
transport
chain,
oxidative
phosphorylation,
tricarboxylic
acid
cycle,
and
fatty
ß-oxidation),
regulation
several
metabolic
processes,
including
redox
homeostasis,
calcium
signalling,
cellular
apoptosis.
The
extensive
studies
conducted
in
last
decades
portray
multifaceted
signalling
organelles
that
ultimately
command
cells'
survival
or
death.
Based
on
current
knowledge,
we'll
outline
mitochondrial
to
other
intracellular
compartments
homeostasis
pathology-related
stress
conditions
here.
following
topics
discussed:
(i)
mtROS
mitohormesis,
(ii)
Ca2+
signalling;
(iii)
anterograde
(nucleus-to-mitochondria)
retrograde
(mitochondria-to-nucleus)
signal
transduction,
(iv)
mtDNA
role
immunity
inflammation,
(v)
induction
mitophagy-
apoptosis
-
cascades,
(vi)
dysfunctions
(mitochondriopathies)
cardiovascular,
neurodegenerative,
malignant
diseases.
novel
insights
into
molecular
mechanisms
mitochondria-mediated
can
explain
adaptation
environmental
stresses
achieve
cell
survival.
Cell Insight,
Год журнала:
2023,
Номер
2(4), С. 100113 - 100113
Опубликована: Июль 22, 2023
Mitochondrial
DNA
(mtDNA)
encodes
proteins
and
RNAs
that
are
essential
for
mitochondrial
function
cellular
homeostasis,
participates
in
important
processes
of
bioenergetics
metabolism.
Alterations
mtDNA
associated
with
various
diseases,
especially
cancers,
considered
as
biomarkers
some
types
tumors.
Moreover,
alterations
have
been
found
to
affect
the
proliferation,
progression
metastasis
cancer
cells,
well
their
interactions
immune
system
tumor
microenvironment
(TME).
The
role
development
makes
it
a
significant
target
treatment.
In
recent
years,
many
novel
therapeutic
methods
targeting
emerged.
this
study,
we
first
discussed
how
cancerogenesis
is
triggered
by
mutations,
including
gene
copy
number,
aberrant
expression
epigenetic
modifications.
Then,
described
detail
mechanisms
underlying
between
extramitochondrial
environment,
which
crucial
understanding
efficacy
safety
mtDNA-targeted
therapy.
Next,
provided
comprehensive
overview
progress
therapy
strategies
mtDNA.
We
classified
them
into
two
categories
based
on
action:
indirect
direct
strategies.
Indirect
aimed
induce
damage
dysfunction
modulating
pathways
involved
stability
integrity,
while
utilized
molecules
can
selectively
bind
or
cleave
achieve
efficacy.
This
study
highlights
importance
treatment,
will
provide
insights
future
research
targeted
drugs
Redox Biology,
Год журнала:
2020,
Номер
42, С. 101846 - 101846
Опубликована: Дек. 25, 2020
Pharmacological
targeting
of
mitochondrial
ion
channels
is
emerging
as
a
promising
approach
to
eliminate
cancer
cells;
most
these
are
differentially
expressed
and/or
regulated
in
cells
comparison
healthy
ones,
this
strategy
may
selectively
the
former.
Perturbation
fluxes
across
outer
and
inner
membranes
linked
alterations
redox
state,
membrane
potential
bioenergetic
efficiency.
This
leads
indirect
modulation
oxidative
phosphorylation,
which
is/may
be
fundamental
for
both
stem
cell
survival.
Furthermore,
given
crucial
contribution
mitochondria
intrinsic
apoptosis,
their
leading
cytochrome
c
release
great
advantage
case
resistance
drugs
triggering
apoptotic
events
upstream
phase.
In
present
review,
we
give
an
overview
known
modulators
capable
killing
cells.
addition,
discuss
state-of-the-art
strategies
using
mitochondriotropic
or
peptide-based
approaches
allowing
more
efficient
selective
channel-linked
events.
International Journal of Biological Sciences,
Год журнала:
2021,
Номер
18(2), С. 585 - 598
Опубликована: Дек. 15, 2021
Background:
Natural
killer
(NK)
cell-based
immunotherapy
is
clinically
limited
due
to
insufficient
tumor
infiltration
in
solid
tumors.
We
have
previously
found
that
the
natural
product
rocaglamide
(RocA)
can
enhance
NK
cell-mediated
killing
of
non-small
cell
lung
cancer
(NSCLC)
cells
by
inhibiting
autophagy,
and
autophagic
inhibition
has
been
shown
increase
melanoma.
Therefore,
we
hypothesized
RocA
could
NSCLC
autophagy
inhibition.
Methods:
Flow
cytometry,
RNA-sequencing,
real-time
PCR,
Western
blotting
analysis,
xenograft
model
were
utilized
assess
underlying
mechanism.
Results:
significantly
increased
expressions
CCL5
CXCL10
cells,
which
not
be
reversed
inhibitions
autophagy/ULK1,
JNK
NF-κB.
However,
such
up-regulation
suppressed
TKB1
STING.
Furthermore,
dramatically
activated
cGAS
(cyclic
GMP-AMP
synthase)-STING
(stimulator
interferon
genes)
signaling
pathway,
inhibition/depletion
STING
ablated
CXCL10,
infiltration,
regression
induced
RocA.
Besides,
damaged
mitochondrial
DNA
(mtDNA)
promoted
cytoplasmic
release
mtDNA.
The
mPTP
inhibitor
cyclosporin
A
reverse
RocA-induced
Conclusions:
promote
activating
cGAS-STING
via
targeting
mtDNA,
but
autophagy.
Taken
together,
our
current
findings
suggested
was
a
potent
agonist
had
promising
potential
immunotherapy,
especially
immunotherapy.
Cancers,
Год журнала:
2022,
Номер
14(5), С. 1207 - 1207
Опубликована: Фев. 25, 2022
Intercellular
communication
is
essential
for
tissue
homeostasis
and
function.
Understanding
how
cells
interact
with
each
other
paramount,
as
crosstalk
between
often
dysregulated
in
diseases
can
contribute
to
their
progression.
Cells
communicate
through
several
modalities,
including
paracrine
secretion
specialized
structures
ensuring
physical
contact
them.
Among
these
intercellular
structures,
tunneling
nanotubes
(TNTs)
are
now
recognized
a
means
of
cell-to-cell
the
exchange
cellular
cargo,
controlled
by
variety
biological
triggers,
described
here.
fundamental
brain
It
allows
dialogue
many
cells,
neurons,
astrocytes,
oligodendrocytes,
glial
microglia,
necessary
proper
development
function
brain.
We
highlight
here
role
TNTs
connecting
physiological
functioning
pathologies
such
stroke,
neurodegenerative
diseases,
gliomas.
processes
could
pave
way
future
therapies.